ATE199910T1 - Peptidderivate der boronsäure mit proteasen inhibierender aktivität, ihr herstellungsverfahren und sie enthaltende pharmazeutische zubereitungen - Google Patents

Peptidderivate der boronsäure mit proteasen inhibierender aktivität, ihr herstellungsverfahren und sie enthaltende pharmazeutische zubereitungen

Info

Publication number
ATE199910T1
ATE199910T1 AT95401462T AT95401462T ATE199910T1 AT E199910 T1 ATE199910 T1 AT E199910T1 AT 95401462 T AT95401462 T AT 95401462T AT 95401462 T AT95401462 T AT 95401462T AT E199910 T1 ATE199910 T1 AT E199910T1
Authority
AT
Austria
Prior art keywords
boronic acid
production process
pharmaceutical preparations
preparations containing
inhibiting activity
Prior art date
Application number
AT95401462T
Other languages
English (en)
Inventor
Nanteuil Guillaume De
Christine Lila
Philippe Gloanec
Michel Laubie
Tony Verbeuren
Serge Simonet
Alain Rupin
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of ATE199910T1 publication Critical patent/ATE199910T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95401462T 1994-06-22 1995-06-21 Peptidderivate der boronsäure mit proteasen inhibierender aktivität, ihr herstellungsverfahren und sie enthaltende pharmazeutische zubereitungen ATE199910T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9407589A FR2721611B1 (fr) 1994-06-22 1994-06-22 Nouveaux dérivés peptidiques de l'acide boronique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent .

Publications (1)

Publication Number Publication Date
ATE199910T1 true ATE199910T1 (de) 2001-04-15

Family

ID=9464456

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95401462T ATE199910T1 (de) 1994-06-22 1995-06-21 Peptidderivate der boronsäure mit proteasen inhibierender aktivität, ihr herstellungsverfahren und sie enthaltende pharmazeutische zubereitungen

Country Status (13)

Country Link
US (1) US5585360A (de)
EP (1) EP0688788B1 (de)
JP (1) JP2862496B2 (de)
CN (1) CN1121077A (de)
AT (1) ATE199910T1 (de)
AU (1) AU686365B2 (de)
CA (1) CA2152205A1 (de)
DE (1) DE69520389D1 (de)
FI (1) FI953089A (de)
FR (1) FR2721611B1 (de)
NO (1) NO952482L (de)
NZ (1) NZ272401A (de)
ZA (1) ZA955176B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825169B1 (en) 1991-10-22 2004-11-30 Trustees Of Tufts College Inhibitors of dipeptidyl-aminopeptidase type IV
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
CA2143533A1 (en) * 1994-03-04 1995-09-05 Kenneth D. Kurz Antithrombotic agents
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5811402A (en) * 1996-03-22 1998-09-22 Eli Lilly And Company Antithrombotic diamides
US5965532A (en) 1996-06-28 1999-10-12 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
AU6896298A (en) 1997-04-14 1998-11-11 Cor Therapeutics, Inc. Selective factor xa inhibitors
WO1998046628A1 (en) * 1997-04-14 1998-10-22 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
WO1998046627A1 (en) 1997-04-14 1998-10-22 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
US6100234A (en) 1997-05-07 2000-08-08 Tufts University Treatment of HIV
US6040145A (en) 1997-05-07 2000-03-21 Tufts University Potentiation of the immune response
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
CN1163594C (zh) 1997-09-29 2004-08-25 尖端医疗有限公司 体外造血细胞的刺激
CA2331122A1 (en) 1998-05-04 1999-11-11 Point Therapeutics, Inc. Hematopoietic stimulation
US6890904B1 (en) 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
PT1399468E (pt) * 2001-05-30 2006-05-31 Novartis Ag Derivados do acido 2-{[n-(2-amino-3-(heteroaril ou aril)propionil)-aminoacil]-amino}-alquilboronico
US20050282757A1 (en) * 2002-09-09 2005-12-22 Trigen Limited Peptide boronic acid compounds useful in anticoagulation
US20050119226A1 (en) * 2003-09-09 2005-06-02 Trigen Limited Methods for synthesizing organoboronic compounds and products thereof
US20060084592A1 (en) * 2002-09-09 2006-04-20 Trigen Limited Peptide boronic acid inhibitors
US20050176651A1 (en) * 2002-09-09 2005-08-11 Trigen Limited Peptide boronic acids useful in making salts thereof
US7112572B2 (en) * 2002-09-09 2006-09-26 Trigen Limited Multivalent metal salts of boronic acids
DE60305113T2 (de) 2002-09-09 2006-12-07 Trigen Ltd. Borsäuresalze und deren Verwendung in der Bereitstellung von Medikamente für die Thrombosebehandlung
GB0405272D0 (en) * 2004-03-09 2004-04-21 Trigen Ltd Compounds
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187157A (en) * 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
GB9017694D0 (en) * 1990-08-13 1990-09-26 Sandoz Ltd Improvements in or relating to organic chemistry
US5288707A (en) * 1990-08-13 1994-02-22 Sandoz Ltd. Borolysine peptidomimetics
GB9024129D0 (en) * 1990-11-06 1990-12-19 Thrombosis Research Trust Inhibitors and substrates of thrombin
FR2701951B1 (fr) * 1993-02-24 1995-06-09 Adir Nouveaux derives peptidiques de l'acide boronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
IL109319A0 (en) * 1993-04-27 1994-07-31 Du Pont Merck Pharma Amidino and guanidino substituted boronic acid compounds
IL111175A0 (en) * 1993-10-07 1994-12-29 Du Pont Merck Pharma Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FI953089A0 (fi) 1995-06-21
DE69520389D1 (de) 2001-04-26
US5585360A (en) 1996-12-17
NO952482L (no) 1995-12-27
ZA955176B (en) 1996-02-08
FR2721611B1 (fr) 1996-09-27
JPH083187A (ja) 1996-01-09
FI953089A (fi) 1995-12-23
NZ272401A (en) 1996-05-28
JP2862496B2 (ja) 1999-03-03
CA2152205A1 (fr) 1995-12-23
NO952482D0 (no) 1995-06-21
AU686365B2 (en) 1998-02-05
FR2721611A1 (fr) 1995-12-29
AU2180195A (en) 1996-01-04
CN1121077A (zh) 1996-04-24
EP0688788A1 (de) 1995-12-27
EP0688788B1 (de) 2001-03-21

Similar Documents

Publication Publication Date Title
ATE199910T1 (de) Peptidderivate der boronsäure mit proteasen inhibierender aktivität, ihr herstellungsverfahren und sie enthaltende pharmazeutische zubereitungen
FI94341C (fi) Menetelmä terapeuttisesti käyttökelpoisten 5-fenyyli-2-pyrimidinonijohdannaisten valmistamiseksi
DE3874844D1 (de) Mehrkernige substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel.
CA2105072A1 (en) Morphinan Derivative and Its Pharmaceutical Applications
BR9505039A (pt) Derivados de oxazolidinona enantiômeros ou diastereômeros dos compostos processo para sua preparação processo para a produção de uma preparação farmacêutica e uso
AU2819992A (en) Hiv protease inhibitors useful for the treatment of aids
ES8401032A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas.
IL71324A (en) N-phenyl-n'-cycloalkylalkanoyl-piperazines,their production and pharmaceutical compositions containing them
HUP9901184A2 (hu) Antibakteriális hatású benzoxazin- és pirido-oxazin-származékok, intermedierjeik, a vegyületeket tartalmazó gyógyászati készítmények, előállításuk és alkalmazásuk
DK705888D0 (da) Pyridazinonderivater
FI92069C (fi) Menetelmä uusien, farmaseuttisesti aktiivisten 1H,3H-pyrrolo/1,2-c/tiatsoli-7-karboksamidijohdannaisten valmistamiseksi
PT96788A (pt) Processo de preparacao de compostos de ureia substituida e de composicoes farmaceuticas
SE9703056L (sv) Klavulansyrasalter, förfarande för framställning därav och farmaceutiska kompositioner innehållande dem
ATE152107T1 (de) 3,9-disubstituierte-spiro (5.5)undecane mit cardiovasculaire wirkung, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate
MY101878A (en) 1,3,4-thiadiazole

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties